Comparison of the Efficacy of Accelerated Intermittent Theta Burst Stimulation and Accelerated Continuous Theta Burst Stimulation in Patients With Treatment-Resistant Depression
NCT07264452
Summary
In recent years, research on the effectiveness of transcranial magnetic stimulation (TMS) in patients with treatment-resistant depression (RTD) has been steadily increasing. The aim of this study was to examine the effectiveness of accelerated unilateral application of two different forms of theta burst stimulation (TBU), a variation of repetitive TMU (rTMS)-intermittent TBU (iTBU) and continuous TBU (cTBU)-in TDD patients. The study aimed to compare the advantages of iTBU and cTBU protocols on depression, suicidal thoughts, anxiety levels, sleep disturbances, cognitive performance, and overall functioning following a two-week intensive treatment period and a 12-week follow-up period.
Eligibility
Inclusion Criteria: 1. 18 to 65 years old 2. Patients diagnosed with Major Depressive Disorder according to DSM 5 and the severity of their illness 3. Scoring 7 points or more on the Maudsley staging method 4. Having depression unresponsive to 2 different antidepressants 5. No clinical mental retardation 6. Agree to participate in the study 7. Hamilton Depression Rating Scale-17 \[HDRS\] score of 20 or higher 8. Montgomery Asberg Depression Rating Scale \[MADRS\] score of 20 or above 9. Being right hand dominant 10. Having used the same antidepressant at the same dose for the last 4 weeks Exclusion Criteria: 1. Diagnosed with a neurological or metabolic disease that affects cognitive functions (Systemic diseases such as diabetes mellitus, cardiovascular disease, cerebrovascular disease, chronic renal failure, Parkinson's disease, multiple sclerosis, polyneuropathy, inflammatory rheumatologic disease and malignancies) 2. Having a foreign body such as a pacemaker, intracranial implant that can magnetically interact 3. Hearing and visual impairments that prevent communication 4. Unstable or acute medical conditions 5. Pregnancy or breastfeeding 6. Having a primary psychiatric disorder other than major depressive disorder 7. Being diagnosed with severe MDD with psychotic features
Conditions7
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07264452